MedPath

Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer

Phase 3
Completed
Conditions
Colorectal Cancer
Interventions
Procedure: 5 cm colon-J-pouch
Procedure: side-to-end anastomosis
Procedure: straight coloanal anastomosis
Registration Number
NCT00238381
Lead Sponsor
Swiss Group for Clinical Cancer Research
Brief Summary

RATIONALE: Rectal reconstruction after surgery to treat rectal cancer may help patients keep some of their bowel function. It is not yet known which method of rectal reconstruction is most effective after surgery.

PURPOSE: This randomized phase III trial is studying three different methods of rectal reconstruction to compare how well they work in treating patients who are undergoing surgery for rectal cancer.

Detailed Description

This is a randomized, multicenter study. Patients are stratified according to participating center, gender, distance of the distal tumor margin from the dentate line (\> 5 cm vs ≀ 5 cm), age (\< 70 vs β‰₯ 70), neoadjuvant chemoradiotherapy (yes vs no), and distant metastasis (M0 vs M1). Patients are randomized to 1 of 3 treatment arms.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
336
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm II5 cm colon-J-pouchPatients undergo TME and colon-J-pouch anastomosis rectal reconstruction.
Arm Iside-to-end anastomosisPatients undergo total mesorectal excision (TME) by standard methods or laparoscopically and side-to-end anastomosis rectal reconstruction.
Arm IIIstraight coloanal anastomosisPatients undergo straight coloanal anastomosis with/without temporary protective ileostomy
Primary Outcome Measures
NameTimeMethod
Composite evacuation score after total mesorectal excision12 months after surgery
Secondary Outcome Measures
NameTimeMethod
Composite incontinence score after total mesorectal excision6, 12, 18 and 24 months
Morbidity2 years follow-up
Quality of life after total mesorectal excision6, 12m 18 and 24 months
Composite evacuation score at 6, 18, and 24 months after total mesorectal excision6, 18 and 24 months after surgery
Overall survival2 years follow-up

Trial Locations

Locations (18)

Kantonsspital Aarau

πŸ‡¨πŸ‡­

Aarau, Switzerland

Kreiskrankenhaus LΓΆrrach

πŸ‡©πŸ‡ͺ

LΓΆrrach, Germany

Inselspital Bern

πŸ‡¨πŸ‡­

Bern, Switzerland

Hopital de La Chaux-de-Fonds

πŸ‡¨πŸ‡­

La Chaux-de-Fonds, Switzerland

Hopitaux Universitaires de Geneve

πŸ‡¨πŸ‡­

Geneva, Switzerland

Kantonsspital Bruderholz

πŸ‡¨πŸ‡­

Bruderholz, Switzerland

Ospedale Beata Vergine

πŸ‡¨πŸ‡­

Mendrisio, Switzerland

Zuger Kantonsspital AG

πŸ‡¨πŸ‡­

Baar, Switzerland

Bezirksspital Dornach

πŸ‡¨πŸ‡­

Dornach, Switzerland

Kantonsspital Winterthur

πŸ‡¨πŸ‡­

Winterthur, Switzerland

Klinik Hirslanden

πŸ‡¨πŸ‡­

Zurich, Switzerland

Universitaetsspital-Basel

πŸ‡¨πŸ‡­

Basel, Switzerland

Centre Hospitalier Universitaire Vaudois

πŸ‡¨πŸ‡­

Lausanne, Switzerland

Kantonsspital Luzern

πŸ‡¨πŸ‡­

Luzerne, Switzerland

UniversitaetsSpital Zuerich

πŸ‡¨πŸ‡­

Zurich, Switzerland

Kantonsspital Olten

πŸ‡¨πŸ‡­

Olten, Switzerland

GZO Spital Wetzikon

πŸ‡¨πŸ‡­

Wetzikon, Switzerland

City Hospital Triemli

πŸ‡¨πŸ‡­

Zurich, Switzerland

Β© Copyright 2025. All Rights Reserved by MedPath